Clinical Trial Update: Palliative Thoracic Radiotherapy Plus BKM120 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating palliative thoracic radiotherapy combined with BKM120 in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BKM120 (Buparlisib)

Snippet

Sponsor: University of Oxford | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2019-08-01